Insider Actions for Deciphera Pharmaceuticals Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 12/15/2021 |
Daniel L. Flynn Chief Scientific Officer |
11,100 | Award at $0 per share. | 0 |
| 12/15/2021 |
Matthew L. Sherman EVP & Chief Medical Officer |
11,100 | Award at $0 per share. | 0 |
| 12/15/2021 |
Daniel C. Martin Chief Commercial Officer |
8,300 | Award at $0 per share. | 0 |
| 12/15/2021 |
Thomas P. Kelly Chief Financial Officer |
11,100 | Award at $0 per share. | 0 |
| 12/15/2021 |
Jama Pitman See Remarks |
8,300 | Award at $0 per share. | 0 |
| 10/04/2021 |
Matthew L. Sherman EVP & Chief Medical Officer |
2,659 | Disposition at $33.17 per share. | 88,199 |
| 05/03/2021 |
Michael D. Taylor Director |
300 | Disposition at $46.75 per share. | 14,025 |
| 05/03/2021 |
Michael D. Taylor Director |
7,700 | Disposition at $46.07 per share. | 354,739 |
| 05/03/2021 |
Michael D. Taylor Director |
5,646 | Derivative/Non-derivative trans. at $3.95 per share. | 22,301 |
| 05/03/2021 |
Michael D. Taylor Director |
2,354 | Derivative/Non-derivative trans. at $1.89 per share. | 4,449 |
| 04/20/2021 |
James A. Bristol Director |
1,700 | Disposition at $45.6 per share. | 77,520 |
| 04/20/2021 |
James A. Bristol Director |
1,700 | Derivative/Non-derivative trans. at $3.95 per share. | 6,715 |
| 04/19/2021 |
James A. Bristol Director |
1,300 | Disposition at $46.66 per share. | 60,658 |
| 04/19/2021 |
James A. Bristol Director |
4,000 | Disposition at $46.13 per share. | 184,520 |
| 04/19/2021 |
James A. Bristol Director |
5,300 | Derivative/Non-derivative trans. at $3.95 per share. | 20,935 |
| 04/12/2021 |
James A. Bristol Director |
5,217 | Disposition at $44.09 per share. | 230,017 |
| 04/12/2021 |
James A. Bristol Director |
9,483 | Disposition at $43.7 per share. | 414,407 |
| 04/12/2021 |
James A. Bristol Director |
14,700 | Derivative/Non-derivative trans. at $3.95 per share. | 58,065 |
| 04/01/2021 |
Michael D. Taylor Director |
906 | Disposition at $46.72 per share. | 42,328 |
| 04/01/2021 |
Michael D. Taylor Director |
4,994 | Disposition at $45.69 per share. | 228,175 |
| 04/01/2021 |
Michael D. Taylor Director |
2,100 | Disposition at $44.8 per share. | 94,080 |
| 04/01/2021 |
Michael D. Taylor Director |
8,000 | Derivative/Non-derivative trans. at $1.89 per share. | 15,120 |
| 03/18/2021 |
Steven L. Hoerter President and CEO; Director |
2,450 | Derivative/Non-derivative trans. at $43.19 per share. | 105,815 |
| 03/18/2021 |
Steven L. Hoerter President and CEO; Director |
700 | Derivative/Non-derivative trans. at $42.39 per share. | 29,673 |
| 03/01/2021 |
Michael D. Taylor Director |
1,104 | Disposition at $44.68 per share. | 49,326 |
| 03/01/2021 |
Michael D. Taylor Director |
6,896 | Disposition at $43.94 per share. | 303,010 |
| 03/01/2021 |
Michael D. Taylor Director |
8,000 | Derivative/Non-derivative trans. at $1.89 per share. | 15,120 |
| 02/16/2021 |
Daniel L. Flynn Chief Scientific Officer |
11,100 | Award at $0 per share. | 0 |
| 02/16/2021 |
Matthew L. Sherman EVP & Chief Medical Officer |
11,100 | Award at $0 per share. | 0 |
| 02/16/2021 |
Thomas P. Kelly Chief Financial Officer |
11,100 | Award at $0 per share. | 0 |
| 02/16/2021 |
Daniel L. Flynn Chief Scientific Officer |
508 | Disposition at $48.87 per share. | 24,825 |
| 02/16/2021 |
Matthew L. Sherman EVP & Chief Medical Officer |
132 | Disposition at $48.87 per share. | 6,450 |
| 02/16/2021 |
Thomas P. Kelly Chief Financial Officer |
524 | Disposition at $48.87 per share. | 25,607 |
